An Ophthalmic Safety Study in Patients With Breast Cancer
Running, not enrolling
Conditions studied: Ophthalmic Safety in Patients With Breast Cancer
In brief
To assess ophthalmic health in parallel cohorts of patients with breast cancer
Key facts
- Study ID
- NCT06767462
- Run by
- AstraZeneca
- People needed
- 160
- Starts
- 2025-03-05
- Expected to finish
- 2027-04-09
- Last updated by the study team
- 2026-06-16
Who can join
Age: 18 and older, up to 130. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Signed informed consent in the qualifying study.
- Signed informed consent in the ophthalmic study prior to any ophthalmic study specific assessments and procedures.
- Completed the baseline ophthalmic examination for this study before the first dose in the qualifying study.
- Meets all the eligibility criteria in the qualifying study
You may not qualify if…
- Patients not randomized and not receiving study assigned treatment in a qualifying study.
- Patients with contraindications to any ophthalmic procedure required by the study or sensitivity/allergy to pupil dilating agents.
- Judgement by the investigator that the patient should not participate in the ophthalmic study if the patient is unlikely to comply with study procedures, restrictions, and requirements
Where it is running
- Research Site — Santiago, Chile
- Research Site — Santiago, Chile
- Research Site — Ashdod, Israel
- Research Site — Nahariya, Israel
- Research Site — Lodz, Poland
- Research Site — Amadora, Portugal
- Research Site — Braga, Portugal
- Research Site — Seoul, South Korea
- Research Site — Badalona, Spain
- Research Site — Barcelona, Spain
- Research Site — Barcelona, Spain
- Research Site — Barcelona, Spain
- Research Site — Girona, Spain
- Research Site — L'Hospitalet de Llobregat, Spain
- Research Site — Leganés, Spain
- Research Site — Madrid, Spain
- Research Site — Madrid, Spain
- Research Site — Madrid, Spain
- Research Site — Madrid, Spain
- Research Site — Madrid, Spain
- Research Site — Madrid, Spain
- Research Site — Madrid, Spain
- Research Site — Majadahonda, Spain
- Research Site — Salamanca, Spain
- Research Site — Sant Joan Despí, Spain
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.